(2021) reported that an anti‐CD47 monoclonal antibody combined with the STING agonist cGAMP (intratumourally administrated) could efficiently enhance the systemic antitumour immune response, prevent tumour metastasis and partially cure tumour‐bearing mice, which is consistent with our results. Here, STING1 is linked to neoplasm.